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Identity 
Alias: Hodgkin's disease (HD) 
Clinics and pathology 
Disease 
Hodgkin lymphoma (HL) involves a clonal expansion 
of neoplastic B lymphocytes. A very small subset of 
cases of classical HL may derive from T cells. 
Epidemiology 
A distinguishing feature with non-Hodgkin's 
lymphomas (NHLs) is its relative frequency in patien s 
under 20 years. 
Pathology 
About 95% of HL belong to the subgroup of classical 
HL, the remaining 5% are lymphocyte predominant 
HL. Most classical HL can be classified as nodular 
sclerotic (NS) or mixed cellularity (MS) subtypes; two 
uncommon subtypes, lymphocyte-rich classical and 
lymphocyte depletion, present less typical pictures and 
examples of the former have sometimes been 
reclassified as low-grade B-cell NHLs. In classical HL, 
the tumor cells are called Hodgkin and Reed-Sternberg 
(HRS) cells, in lymphocyte predominant HL they are 
nowadays called LP cells (previously LH, lymphocyti 
and histiocytic, cells). 
Prognosis 
Unlike NHLs, the prognosis of HD has improved in 






Several recurrent genetic lesions have been identifi d 
in HRS cells of classical HL. The most frequently 
found lesions affect members of the NF-kappaB or 
JAK/STAT signaling pathways: inactivating mutation 
in NFKBIA (10-20% of cases), NFKBIE (ca. 10% of 
cases), TNFAIP3 (40%), SOCS1 (40%), genomic gains 
of REL (30%) and JAK2 (30%) and rare BCL3 
translocations. TNFAIP3 mutations are mainly found in 
Epstein-Barr virus-negative cases of HL, suggesting 
that TNFAIP3 mutations and EBV infection are 
alternative pathogenetic mechanisms in HL. In very 
rare instances, mutations have been found in the tumor 
suppressor genes CD95 and TP53. Four or six cases 
analysed were found to harbor gains of MDM2. Further 
genomic imbalances have been identified by 
comparative genomic hybridization studies; these 
include gains of IKBKB, CD40 and MAP3K14, i.e. 
further regulators of NF-kappaB signalling. 
Few genetic lesions are known for LP cells of 
lymphocyte predominant HL: mutations in SOCS1 and 
translocations involving the BCL6 protooncogene. 
Mutations in TNFAIP3 or NFKBIA seem to play no 
role in LP cells, although they also show strong NF-
kappaB activity. 
Both HRS and LP cells show aberrant somatic 
hypermutation of several proto-oncogenes (PIM1, 
Rho/TTF, MYC, PAX5) in a considerable fraction of 
cases. However, as most mutations are in the 5' 
untranslated regions of the genes, it is unclear whether 
or which fractions of these mutations have a 
pathogenetic relevance. 
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Cytogenetics 
Cytogenetics morphological 
The neoplastic cells in typical HL lymph nodes 
comprise mononuclear Hodgkin and multilobate, 
binucleate or multinucleate Reed-Sternberg cells, and 
that these are clonal with modal chromosome numbers 
varying from case to case is indicated from direct 
chromosome analysis and DNA measurements and 
directly shown by the detection of clonal 
immunoglobulin V gene rearrangements in isolated 
HRS cells. 
The modes are about twice as frequently in the triploid-
tetraploid (particularly 65-80 chromosomes) as 
neardiploid region; the clonal aneuploidy has been 
demonstrated by simultaneous fluorescence 
immunophenotyping and interphase chromosomal 
analysis to occur in the Hodgkin and Reed-Sternberg 
cells. 
Unlike NHLs, where a number of chromosomal 
translocations specific for histopathological types of 
tumor have been discovered, similarly specific changes 
have unfortunately not been reported for HD; 
occasionally, translocations such as t(14;18) that are 
common in specific types of NHL have been found; 
translocations involving the immunoglobulin loci have 
been found in about 20% of classical HL, but the 
partner genes are mostly still unknown; deletions ad
duplications, common in other types of tumor, 
including NHLs, have been described in HL, such as 
del(1p), dup(1q), del(6q) and del(7q); a nonrandom 
change involving chromosome 4, with breakpoints in 
the region 4q25-28, has been found on several 
occasions and merits further investigation. 
In chromosome studies, both direct and after culturing, 
diploid as well as aneuploid metaphases are commonly 
found in HD, not unexpectedly since histopathological 
studies usually reveal a considerable excess of 
lymphocytes and other cells with normal morphology 
compared to the aneuploid Hodgkin and Reed-
Sternberg cells; a recent intriguing finding using FISH, 
however, has been that 1-12% of "normal" nuclei in 
HD have abnormalities, most commonly trisomies for 
various chromosomes. 
The multinucleated Reed-Sternberg cells most likely 
derive from mononucleated Hodgkin cells through a 
process similar to endomitosis, i.e. nuclear division 
without cell division. 
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